KETOCONAZOLE 1%

KETOCONAZOLE 1% was reported 122 times

KETOCONAZOLE 1% is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 RENAL HAMARTOMA 1 0.0179
1 APPLICATION SITE PUSTULES 1 0.0027
2 PRE-EXISTING DISEASE 1 0.0021
3 BODY TINEA 1 0.0018
4 DANDRUFF 3 0.0014
5 PRODUCT CONTAINER SEAL ISSUE 2 0.0011
6 FOREIGN BODY IN EYE 1 0.0010
7 NASAL PRURITUS 1 0.0008
8 TRICHORRHEXIS 2 0.0007
9 SMEAR CERVIX ABNORMAL 1 0.0007
10 KERATOPATHY 1 0.0006
11 CERVICAL SPINAL STENOSIS 1 0.0006
12 PRODUCT TAMPERING 1 0.0006
13 HAIR TEXTURE ABNORMAL 7 0.0005
14 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
15 APPLICATION SITE DISCOLOURATION 2 0.0005
16 RENAL NEOPLASM 1 0.0005
17 CERVICAL DYSPLASIA 1 0.0005
18 PRODUCT LABEL ISSUE 3 0.0004
19 REACTION TO EXCIPIENT 1 0.0004
20 HAIR COLOUR CHANGES 5 0.0004
21 HAIR DISORDER 3 0.0004
22 SEBORRHOEA 1 0.0003
23 PROSTATOMEGALY 1 0.0003
24 FUNGAL SKIN INFECTION 1 0.0002
25 APPLICATION SITE EXFOLIATION 1 0.0002
26 THERAPEUTIC RESPONSE UNEXPECTED 10 0.0002
27 APPLICATION SITE BURN 1 0.0002
28 APPLICATION SITE SWELLING 1 0.0002
29 PRODUCT COLOUR ISSUE 1 0.0002
30 PRODUCT ODOUR ABNORMAL 2 0.0002
31 DRUG ADMINISTERED AT INAPPROPRIATE SITE 2 0.0002
32 PRODUCT PHYSICAL CONSISTENCY ISSUE 1 0.0002
33 NERVE INJURY 2 0.0002
34 SKIN ATROPHY 1 0.0002
35 SINUS HEADACHE 1 0.0002
36 TYPE 1 DIABETES MELLITUS 1 0.0002
37 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 11 0.0002
38 BREAST MASS 1 0.0001
39 THERMAL BURN 1 0.0001
40 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0001
41 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 1 0.0001
42 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 1 0.0001
43 SKIN DISORDER 4 0.0001
44 PRODUCT CONTAINER ISSUE 1 0.0001
45 ERYTHEMA MULTIFORME 1 0.0001
46 PRODUCT PACKAGING ISSUE 1 0.0001
47 DRUG PRESCRIBING ERROR 2 0.0001
48 VITAMIN D DEFICIENCY 1 0.0001
49 COELIAC DISEASE 1 0.0001
50 THERAPY CHANGE 1 0.0001
51 CONTRAINDICATED PRODUCT ADMINISTERED 3 0.0001
52 VAGINAL DISCHARGE 1 0.0001
53 BODY HEIGHT DECREASED 1 0.0001
54 ALOPECIA 18 0.0001
55 APPLICATION SITE PAIN 2 0.0001
56 EXPIRED PRODUCT ADMINISTERED 3 0.0001
57 FUNGAL INFECTION 3 0.0001
58 SKIN INFECTION 1 0.0001
59 THYROID CANCER 1 0.0001
60 WRONG TECHNIQUE IN DRUG USAGE PROCESS 3 0.0001
61 APPLICATION SITE IRRITATION 1 0.0001
62 PRODUCT USE ISSUE 15 0.0001
63 APPLICATION SITE ERYTHEMA 2 0.0001
64 IMMUNE SYSTEM DISORDER 1 0.0001
65 SKIN REACTION 1 0.0001
66 PARAESTHESIA ORAL 1 0.0001
67 SKIN HAEMORRHAGE 1 0.0001
68 HAEMORRHAGE INTRACRANIAL 1 0.0001
69 OSTEOPENIA 1 0.0001
70 TOXIC EPIDERMAL NECROLYSIS 1 0.0001
71 SKIN IRRITATION 3 0.0001
72 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
73 DRUG ERUPTION 1 0.0001
74 GASTROENTERITIS VIRAL 1 0.0001
75 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
76 ACNE 4 0.0001
77 FOOT FRACTURE 1 0.0001
78 MUSCULOSKELETAL DISORDER 1 0.0001
79 SLEEP APNOEA SYNDROME 1 0.0001
80 POST PROCEDURAL COMPLICATION 1 0.0001
81 SINUS DISORDER 1 0.0001
82 OSTEOPOROSIS 2 0.0000
83 RIB FRACTURE 1 0.0000
84 SKIN EXFOLIATION 4 0.0000
85 STEVENS-JOHNSON SYNDROME 1 0.0000
86 TOOTH DISORDER 1 0.0000
87 APPLICATION SITE PRURITUS 1 0.0000
88 MENTAL IMPAIRMENT 1 0.0000
89 CEREBRAL INFARCTION 1 0.0000
90 ABDOMINAL PAIN LOWER 1 0.0000
91 SKIN ULCER 1 0.0000
92 ANHEDONIA 1 0.0000
93 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
94 ABNORMAL DREAMS 1 0.0000
95 WOUND 1 0.0000
96 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
97 LIVER FUNCTION TEST ABNORMAL 1 0.0000
98 INTENTIONAL PRODUCT MISUSE 3 0.0000
99 PRURITUS 13 0.0000
100 DRUG ADMINISTRATION ERROR 1 0.0000
101 BONE DENSITY DECREASED 1 0.0000
102 HEAD INJURY 1 0.0000
103 EYE DISORDER 1 0.0000
104 LIP SWELLING 1 0.0000
105 HEART RATE DECREASED 1 0.0000
106 HYPOXIA 1 0.0000
107 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
108 PANIC ATTACK 1 0.0000
109 CHRONIC KIDNEY DISEASE 2 0.0000
110 ABNORMAL BEHAVIOUR 1 0.0000
111 EXTRA DOSE ADMINISTERED 1 0.0000
112 ERYTHEMA 5 0.0000
113 DRUG DOSE OMISSION 4 0.0000
114 THROAT IRRITATION 1 0.0000
115 SKIN DISCOLOURATION 1 0.0000
116 RENAL DISORDER 1 0.0000
117 RENAL CANCER 1 0.0000
118 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
119 DRUG INEFFECTIVE 26 0.0000
120 INFLAMMATION 1 0.0000
121 DERMATITIS ATOPIC 1 0.0000
122 DRUG EFFECT DECREASED 1 0.0000
123 OEDEMA 1 0.0000
124 TREATMENT NONCOMPLIANCE 1 0.0000
125 MEDICATION ERROR 1 0.0000
126 NECK PAIN 1 0.0000
127 BLISTER 1 0.0000
128 ASTHMA 2 0.0000
129 EYE IRRITATION 1 0.0000
130 CATARACT 1 0.0000
131 FEELING HOT 1 0.0000
132 DRY SKIN 2 0.0000
133 BURNING SENSATION 1 0.0000
134 SLEEP DISORDER 1 0.0000
135 SKIN BURNING SENSATION 1 0.0000
136 BRONCHITIS 1 0.0000
137 DYSGEUSIA 1 0.0000
138 DIABETES MELLITUS 1 0.0000
139 DRY MOUTH 1 0.0000
140 RENAL IMPAIRMENT 1 0.0000
141 RASH 5 0.0000
142 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
143 ADVERSE DRUG REACTION 1 0.0000
144 HYPERSENSITIVITY 2 0.0000
145 CARDIAC DISORDER 1 0.0000
146 NEUROPATHY PERIPHERAL 1 0.0000
147 CONDITION AGGRAVATED 3 0.0000
148 OVERDOSE 2 0.0000
149 CONSTIPATION 2 0.0000
150 DEPRESSION 2 0.0000
151 CHILLS 1 0.0000
152 EMOTIONAL DISTRESS 1 0.0000
153 OEDEMA PERIPHERAL 1 0.0000
154 PRODUCT USE IN UNAPPROVED INDICATION 2 0.0000
155 PSORIASIS 1 0.0000
156 DEHYDRATION 1 0.0000
157 COUGH 2 0.0000
158 INFECTION 1 0.0000
159 OFF LABEL USE 6 0.0000
160 PARAESTHESIA 1 0.0000
161 TREMOR 1 0.0000
162 URTICARIA 1 0.0000
163 MYALGIA 1 0.0000
164 URINARY TRACT INFECTION 1 0.0000
165 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
166 NASOPHARYNGITIS 1 0.0000
167 CHEST PAIN 1 0.0000
168 ASTHENIA 2 0.0000
169 BLOOD GLUCOSE INCREASED 1 0.0000
170 ANAEMIA 1 0.0000
171 HYPOTENSION 1 0.0000
172 ABDOMINAL PAIN UPPER 1 0.0000
173 HEADACHE 3 0.0000
174 WEIGHT INCREASED 1 0.0000
175 INCORRECT DOSE ADMINISTERED 1 0.0000
176 DECREASED APPETITE 1 0.0000
177 BACK PAIN 1 0.0000
178 DIZZINESS 2 0.0000
179 INSOMNIA 1 0.0000
180 WEIGHT DECREASED 1 0.0000
181 PRODUCT DOSE OMISSION ISSUE 1 0.0000
182 PAIN IN EXTREMITY 1 0.0000
183 PAIN 2 0.0000
184 DIARRHOEA 2 0.0000
185 FALL 1 0.0000
186 FATIGUE 2 0.0000
187 ARTHRALGIA 1 0.0000
188 MALAISE 1 0.0000
189 NAUSEA 1 0.0000
190 DEATH 1 0.0000